Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peng Qu

Showing results (241-250 of 297) with videos related to

Pageof 30
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 21, 2025
Engineered Multifunctional Hydrogel Delivering Novel CBX7 Inhibitor Modulates Cuproptosis Via Liquid-Liquid Phase Separation to Restore Cardiac Function in Aged Myocardial InfarctionJun Liu, Peng Qu, Jiao Shi, et al.
Scientific Reports|August 2, 2025
The risk of heart-specific death in breast cancer patientsYunbo Luo, Long Zhao, Peng Qu, et al.
Frontiers in Cellular and Infection Microbiology|July 26, 2022
<i>Saccharomyces boulardii</i> Allows Partial Patients to Avoid Reusing Bismuth Quadruple for <i>Helicobacter pylori</i> Rescue Therapy: A Single-Center Randomized Controlled StudyPeng Qu, Xiaoming Liu, Xiujuan Xia, et al.
Frontiers in Immunology|March 14, 2024
Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetesTongtong Liu, Hailing Zhao, Ying Wang, et al.
International Journal of Molecular Medicine|March 12, 2015
P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activationKuang Peng, Lushan Liu, Dangheng Wei, et al.
Asian Journal of Surgery|April 19, 2024
Efficacy of immune checkpoint inhibitors for NSCLC in patients with different age: A systematic review and meta-analysisQi Zhang, Xiao-Yan Liang, Ze-Sheng Wang, et al.
Materials Today. Bio|February 5, 2025
A select inhibitor of MORC2 encapsulated by chimeric membranecoated DNA nanocage target alleviation TNBC progressionXiaohan Su, Yunbo Luo, Yali Wang, et al.
BMC Cardiovascular Disorders|September 18, 2024
Unraveling the rapid progression of non-target lesions: risk factors and the therapeutic potential of PCSK9 inhibitors in post-PCI patientsJiajie Mei, Xiaodan Fu, Zhenzhu Liu, et al.
Biosensors & Bioelectronics|February 25, 2018
Hierarchical CuInS<sub>2</sub>-based heterostructure: Application for photocathodic bioanalysis of sarcosineXin-Yuan Jiang, Ling Zhang, Yi-Li Liu, et al.
Heliyon|September 24, 2024
Effect of amubarvimab-romlusevimab for treatment of severe COVID-19 in intensive care units: A retrospective cohort studyPeng Qu, Anni Lou, Dan Rong, et al.
Pageof 30

Showing results (241-250 of 297) with videos related to

Sort By:
Pageof 30
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 21, 2025
Engineered Multifunctional Hydrogel Delivering Novel CBX7 Inhibitor Modulates Cuproptosis Via Liquid-Liquid Phase Separation to Restore Cardiac Function in Aged Myocardial InfarctionJun Liu, Peng Qu, Jiao Shi, et al.
Scientific Reports|August 2, 2025
The risk of heart-specific death in breast cancer patientsYunbo Luo, Long Zhao, Peng Qu, et al.
Frontiers in Cellular and Infection Microbiology|July 26, 2022
<i>Saccharomyces boulardii</i> Allows Partial Patients to Avoid Reusing Bismuth Quadruple for <i>Helicobacter pylori</i> Rescue Therapy: A Single-Center Randomized Controlled StudyPeng Qu, Xiaoming Liu, Xiujuan Xia, et al.
Frontiers in Immunology|March 14, 2024
Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetesTongtong Liu, Hailing Zhao, Ying Wang, et al.
International Journal of Molecular Medicine|March 12, 2015
P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activationKuang Peng, Lushan Liu, Dangheng Wei, et al.
Asian Journal of Surgery|April 19, 2024
Efficacy of immune checkpoint inhibitors for NSCLC in patients with different age: A systematic review and meta-analysisQi Zhang, Xiao-Yan Liang, Ze-Sheng Wang, et al.
Materials Today. Bio|February 5, 2025
A select inhibitor of MORC2 encapsulated by chimeric membranecoated DNA nanocage target alleviation TNBC progressionXiaohan Su, Yunbo Luo, Yali Wang, et al.
BMC Cardiovascular Disorders|September 18, 2024
Unraveling the rapid progression of non-target lesions: risk factors and the therapeutic potential of PCSK9 inhibitors in post-PCI patientsJiajie Mei, Xiaodan Fu, Zhenzhu Liu, et al.
Biosensors & Bioelectronics|February 25, 2018
Hierarchical CuInS<sub>2</sub>-based heterostructure: Application for photocathodic bioanalysis of sarcosineXin-Yuan Jiang, Ling Zhang, Yi-Li Liu, et al.
Heliyon|September 24, 2024
Effect of amubarvimab-romlusevimab for treatment of severe COVID-19 in intensive care units: A retrospective cohort studyPeng Qu, Anni Lou, Dan Rong, et al.
Pageof 30